You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

ASHLYNA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Ashlyna, and when can generic versions of Ashlyna launch?

Ashlyna is a drug marketed by Glenmark Pharms Ltd and is included in one NDA.

The generic ingredient in ASHLYNA is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ASHLYNA?
  • What are the global sales for ASHLYNA?
  • What is Average Wholesale Price for ASHLYNA?
Drug patent expirations by year for ASHLYNA
Drug Prices for ASHLYNA

See drug prices for ASHLYNA

Drug Sales Revenue Trends for ASHLYNA

See drug sales revenues for ASHLYNA

US Patents and Regulatory Information for ASHLYNA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Pharms Ltd ASHLYNA ethinyl estradiol; levonorgestrel TABLET;ORAL 203163-001 Feb 23, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.